Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Further characterization of bovine hepacivirus: Antibody response, course of infection, and host tropism.

Baechlein C, Baron AL, Meyer D, Gorriz-Martin L, Pfankuche VM, Baumgärtner W, Polywka S, Peine S, Fischer N, Rehage J, Becher P.

Transbound Emerg Dis. 2019 Jan;66(1):195-206. doi: 10.1111/tbed.12999. Epub 2018 Sep 8.

PMID:
30126081
2.

Course of HEV viremia and anti-HEV IgM/IgG response in asymptomatic blood donors.

Kraef C, Schlein C, Hiller J, Westhölter D, Denzer U, Horvatits T, Peine S, Lohse AW, Lütgehetmann M, Polywka S, Pischke S.

J Clin Virol. 2018 Aug;105:26-30. doi: 10.1016/j.jcv.2018.05.013. Epub 2018 May 29.

PMID:
29860111
3.

HEV-positive blood donations represent a relevant infection risk for immunosuppressed recipients.

Westhölter D, Hiller J, Denzer U, Polywka S, Ayuk F, Rybczynski M, Horvatits T, Gundlach S, Blöcker J, Schulze Zur Wiesch J, Fischer N, Addo MM, Peine S, Göke B, Lohse AW, Lütgehetmann M, Pischke S.

J Hepatol. 2018 Jul;69(1):36-42. doi: 10.1016/j.jhep.2018.02.031. Epub 2018 Mar 15.

PMID:
29551705
4.

Autoantibodies against "rods and rings"-related IMPDH2 in hepatitis C genotype 1 and DAA therapy in a "real life" cohort.

Dammermann W, Polywka S, Dettmann I, Mindorf S, Komorowski L, Wehmeyer M, Schulze Zur Wiesch J, Stöcker W, Lüth S.

Med Microbiol Immunol. 2017 Oct;206(5):379-382. doi: 10.1007/s00430-017-0516-z. Epub 2017 Aug 16.

PMID:
28815296
5.

High clinical manifestation rate in an imported outbreak of hepatitis E genotype 1 infection in a German group of travellers returning from India.

Pischke S, Schulze-Zur-Wiesch J, Lütgehetmann M, Kreuels B, Lueth S, Kapaun P, Benten D, Schmiedel S, Sterneck M, Lohse AW, Polywka S.

Ann Hepatol. 2017 Jan-Feb;16(1):57-62. doi: 10.5604/16652681.1226815.

6.

High Clinical Manifestation Rate in an Imported Outbreak of Hepatitis E Genotype 1 Infection in a German Group of Travellers Returning from India.

Pischke S, Schulze-Zur-Wiesch J, Lütgehetmann M, Kreuels B, Lueth S, Kapaun P, Benten D, Schmiedel S, Sterneck M, Lohse AW, Polywka S.

Ann Hepatol. 2017 Jan - Feb;16(1):57-62. doi: 10.5604/16652681.1226815.

7.

Breadth of the HCV-specific CD4+ T-cell response in spontaneous resolvers is independent of the IL-28 haplotype.

Scheurich C, Schulze Zur Wiesch J, Kim AY, Lewis-Ximenez L, Meyer T, Polywka S, Chung RT, Lauer GM.

J Viral Hepat. 2016 Oct;23(10):831-2. doi: 10.1111/jvh.12560. Epub 2016 Jun 27. No abstract available.

PMID:
27346754
8.

Blood-borne Hepatitis E Virus Transmission: A Relevant Risk for Immunosuppressed Patients.

Pischke S, Hiller J, Lütgehetmann M, Polywka S, Rybczynski M, Ayuk F, Lohse AW.

Clin Infect Dis. 2016 Aug 15;63(4):569-70. doi: 10.1093/cid/ciw309. Epub 2016 May 13. No abstract available.

PMID:
27178472
9.

Persisting hepatitis E virus infection leading to liver cirrhosis despite recovery of the immune system in an HIV-infected patient.

Ingiliz P, Mayr C, Obermeier M, Herbst H, Polywka S, Pischke S.

Clin Res Hepatol Gastroenterol. 2016 Jun;40(3):e23-e25. doi: 10.1016/j.clinre.2016.01.005. Epub 2016 Apr 4.

PMID:
27055386
10.

Efficacy and safety of sofosbuvir/ledipasvir for the treatment of patients with hepatitis C virus re-infection after liver transplantation.

Ciesek S, Proske V, Otto B, Pischke S, Costa R, Lüthgehetmann M, Polywka S, Klempnauer J, Nashan B, Manns MP, von Hahn T, Lohse AW, Wedemeyer H, Mix H, Sterneck M.

Transpl Infect Dis. 2016 Jun;18(3):326-32. doi: 10.1111/tid.12524. Epub 2016 May 10.

PMID:
26988272
11.

Human liver chimeric mice as a new model of chronic hepatitis E virus infection and preclinical drug evaluation.

Allweiss L, Gass S, Giersch K, Groth A, Kah J, Volz T, Rapp G, Schöbel A, Lohse AW, Polywka S, Pischke S, Herker E, Dandri M, Lütgehetmann M.

J Hepatol. 2016 May;64(5):1033-1040. doi: 10.1016/j.jhep.2016.01.011. Epub 2016 Jan 22.

PMID:
26805671
12.

Course of hepatitis C virus (HCV) RNA and HCV core antigen testing are predictors for reaching sustained virologic response in liver transplant recipients undergoing sofosbuvir treatment in a real-life setting.

Pischke S, Polywka S, Proske VM, Lang M, Jordan S, Nashan B, Lohse AW, Sterneck M.

Transpl Infect Dis. 2016 Feb;18(1):141-5. doi: 10.1111/tid.12475. Epub 2016 Jan 30.

PMID:
26485543
13.

Definition of chronic hepatitis E after liver transplant conforms to convention.

Meisner S, Polywka S, Memmler M, Nashan B, Lohse AW, Sterneck M, Pischke S.

Am J Transplant. 2015 Nov;15(11):3011-2. doi: 10.1111/ajt.13428. Epub 2015 Aug 19. No abstract available.

14.

Comparison of autochthonous and imported cases of hepatitis A or hepatitis E.

Hartl J, Kreuels B, Polywka S, Addo M, Luethgehetmann M, Dandri M, Dammermann W, Sterneck M, Lohse AW, Pischke S.

Z Gastroenterol. 2015 Jul;53(7):639-43. doi: 10.1055/s-0034-1399236. Epub 2015 Jul 13.

PMID:
26167693
15.

Relevance of chronic hepatitis E in liver transplant recipients: a real-life setting.

Galante A, Pischke S, Polywka S, Luetgehethmann M, Suneetha PV, Gisa A, Hiller J, Dienes HP, Nashan B, Lohse AW, Sterneck M.

Transpl Infect Dis. 2015 Aug;17(4):617-22. doi: 10.1111/tid.12411. Epub 2015 Jul 14.

PMID:
26094550
16.

Association of hepatitis E virus and essential cryoglobulinemia?

Pischke S, Polywka S, Haag F, Iking-Konert C, Sterneck M, Lütgehetmann M, Dammermann W, Lüth S, Schirmer JH.

J Clin Virol. 2015 Jun;67:23-4. doi: 10.1016/j.jcv.2015.03.020. Epub 2015 Mar 28. No abstract available.

PMID:
25959152
17.

New foe treated with old guns - supportive role of steroids in the treatment of acute severe hepatitis E.

Sebode M, Pischke S, Lütgehetmann M, Polywka S, Quaas A, Lohse AW, Wege H.

BMC Gastroenterol. 2014 Nov 15;14:191. doi: 10.1186/s12876-014-0191-0.

18.

Improved detection of bacterial central nervous system infections by use of a broad-range PCR assay.

Meyer T, Franke G, Polywka SK, Lütgehetmann M, Gbadamosi J, Magnus T, Aepfelbacher M.

J Clin Microbiol. 2014 May;52(5):1751-3. doi: 10.1128/JCM.00469-14. Epub 2014 Mar 12.

19.

Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection.

Giersch K, Helbig M, Volz T, Allweiss L, Mancke LV, Lohse AW, Polywka S, Pollok JM, Petersen J, Taylor J, Dandri M, Lütgehetmann M.

J Hepatol. 2014 Mar;60(3):538-44. doi: 10.1016/j.jhep.2013.11.010. Epub 2013 Nov 23.

PMID:
24280293
20.

Viral hepatitis in alcohol-dependent inpatients: prevalence, risk factors, and treatment uptake.

Schmidt CS, Schön D, Schulte B, Lüth S, Polywka S, Reimer J.

J Addict Med. 2013 Nov-Dec;7(6):417-21. doi: 10.1097/ADM.0b013e3182a50817.

PMID:
24189174
21.

Is rapid hepatitis C virus testing from corpses a screening option for index persons who have died after mass-casualty incidents in high-prevalence settings in the field?

Hagen RM, Wulff B, Loderstaedt U, Fengler I, Frickmann H, Schwarz NG, Polywka S.

J R Army Med Corps. 2014 Sep;160(3):226-31. doi: 10.1136/jramc-2013-000133. Epub 2013 Oct 10.

PMID:
24113204
22.

Virus NAT for HIV, HBV, and HCV in Post-Mortal Blood Specimens over 48 h after Death of Infected Patients - First Results.

Meyer T, Polywka S, Wulff B, Edler C, Schröder AS, Wilkemeyer I, Kalus U, Pruss A.

Transfus Med Hemother. 2012 Dec;39(6):376-80. doi: 10.1159/000345610. Epub 2012 Nov 19.

23.

From IEDs to AIDS? Detection of HIV in human corpses by rapid screening tests after suspected intentional transmission in terrorist attacks.

Frickmann H, Wulff B, Loderstædt U, Hagen RM, Sturm D, Polywka S.

J R Army Med Corps. 2013 Dec;159(4):278-82. doi: 10.1136/jramc-2013-000048. Epub 2013 Mar 27.

PMID:
23720507
24.

A prospective time-course study on serological testing for human immunodeficiency virus, hepatitis B virus and hepatitis C virus with blood samples taken up to 48 h after death.

Edler C, Wulff B, Schröder AS, Wilkemeyer I, Polywka S, Meyer T, Kalus U, Pruss A.

J Med Microbiol. 2011 Jul;60(Pt 7):920-6. doi: 10.1099/jmm.0.027763-0. Epub 2011 Mar 24.

PMID:
21436373
25.

An unusual cause of elevated liver function tests in an elderly female.

Frickmann H, Gabriel M, Polywka S, Bonow I, Günther S, Schmidt-Chanasit J.

J Clin Virol. 2011 Jun;51(2):93-5. doi: 10.1016/j.jcv.2011.02.012. Epub 2011 Mar 22. No abstract available.

PMID:
21429790
26.

Accuracy of HCV-RNA PCR tests for diagnosis or exclusion of vertically acquired HCV infection.

Polywka S, Pembrey L, Tovo PA, Newell ML.

J Med Virol. 2006 Feb;78(2):305-10.

PMID:
16372293
27.

A new combined HIV p24 antigen and anti-HIV-1/2/O screening assay.

Polywka S, Duttmann H, Lübben F, Laufs R, Feldner J.

Methods Mol Biol. 2005;304:229-43.

PMID:
16061980
28.

Prolonged time until seroconversion among hemodialysis patients: the need for HCV PCR.

Schroeter M, Zoellner B, Polywka S, Laufs R, Feucht HH.

Intervirology. 2005;48(4):213-5.

PMID:
15920344
29.

Guidelines for the treatment of hepatitis C virus infection in injection drug users: status quo in the European Union countries.

Reimer J, Schulte B, Castells X, Schafer I, Polywka S, Hedrich D, Wiessing L, Haasen C, Backmund M, Krausz M.

Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S373-8. Review.

PMID:
15768351
30.

Inter-laboratory comparison of HCV-RNA assay results: implications for multi-centre research.

Pembrey L, Newell ML, Tovo PA, van Drimmelen H, Quinti I, Furlini G, Galli S, Meliconi MG, Burns S, Hallam N, Sönnerborg A, Cilla G, Serrano E, Laccetti P, Portella G, Polywka S, Icardi G, Bruzzone B, Balbo L, Alfarano A; European Paediatric Hepatitis C Virus Network.

J Med Virol. 2003 Feb;69(2):195-201.

PMID:
12683407
31.

The efficiency of humoral immune transfer depends on both the graft and the immunosuppressive treatment.

Dahmen U, Li J, Gu Y, Doebel L, Fan LM, Polywka S, Dirsch O, Broelsch CE.

Transpl Int. 2003 Mar;16(3):161-7. Epub 2003 Feb 5.

PMID:
12664210
32.

Adoptive transfer of donor-derived immunity by liver transplantation: a potential avenue to prevent hepatitis B virus reinfection.

Dahmen U, Li J, Dirsch O, Gu YL, Polywka S, Doebel L, Shen K, Broelsch CE.

J Viral Hepat. 2003 Jan;10(1):31-6.

PMID:
12558909
33.

[Hepatitis C. Virology, transmission modes, clinical aspects, prevention and therapy].

Laufs R, Polywka S, Feucht HH, Schröter M, Zöllner B, Oehler G.

Anaesthesist. 2002 Nov;51(11):884-9. Review. German.

PMID:
12434261
34.

Adoptive transfer of HBV immunity by kidney transplantation and the effect of postoperative vaccination.

Dahmen U, Gu Y, Dirsch O, Li J, Polywka S, Doebel L, Shen K, Broelsch CE.

Antiviral Res. 2002 Oct;56(1):29-37.

PMID:
12323397
35.

Prolonged suppression of humoral immune response after organ transplantation.

Gu YL, Dahmen U, Li J, Dirsch O, Polywka S, Broelsch CE.

Eur Surg Res. 2002 May-Jun;34(3):260-5.

PMID:
12077514
36.

The potential role of bone marrow transplantation in augmenting donor-derived immunity to hepatitis B after rat liver transplantation.

Li J, Dahmen U, Dirsch OR, Gu Y, Polywka S, Fiedler M, Doebel L, Roggendorf M, Broelsch CE.

Liver Transpl. 2002 Apr;8(4):397-404.

37.

Diagnostic evaluation of a new combined HIV p24 antigen and anti-HIV1/2/O screening assay.

Polywka S, Feldner J, Duttmann H, Laufs R.

Clin Lab. 2001;47(7-8):351-6.

PMID:
11499796
38.

Strategies for reliable diagnosis of hepatitis C infection: the need for a serological confirmatory assay.

Schröter M, Schäfer P, Zöllner B, Polywka S, Laufs R, Feucht HH.

J Med Virol. 2001 Jul;64(3):320-4.

PMID:
11424121
39.

Relevance of reactivity in commercially available hepatitis C virus antibody assays.

Polywka S, Schröter M, Feucht HH, Zöllner B, Laufs R.

J Clin Microbiol. 2001 Apr;39(4):1665-8.

40.

Influence of CsA treatment on adoptive transfer of immunity after allogeneic kidney transplantation in rats.

Gu YL, Dahmen U, Doebel L, Li J, Dirsch O, Polywka S, Broelsch CE.

Transplant Proc. 2001 Feb-Mar;33(1-2):398-400. No abstract available.

PMID:
11266880
41.

Reactivation of hepatitis B virus replication accompanied by acute hepatitis in patients receiving highly active antiretroviral therapy.

Manegold C, Hannoun C, Wywiol A, Dietrich M, Polywka S, Chiwakata CB, Günther S.

Clin Infect Dis. 2001 Jan;32(1):144-8. Epub 2000 Dec 13.

PMID:
11118394
42.

Detection of TT virus DNA and GB virus type C/Hepatitis G virus RNA in serum and breast milk: determination of mother-to-child transmission.

Schröter M, Polywka S, Zöllner B, Schäfer P, Laufs R, Feucht HH.

J Clin Microbiol. 2000 Feb;38(2):745-7.

43.

Low risk of vertical transmission of hepatitis C virus by breast milk.

Polywka S, Schröter M, Feucht HH, Zöllner B, Laufs R.

Clin Infect Dis. 1999 Nov;29(5):1327-9.

PMID:
10524987
44.

High rate of chronicity in HCV infection determined by antibody confirmatory assay and PCR in 4110 patients during long-term follow-up.

Feucht HH, Zöllner B, Schröter M, Polywka S, Buggisch P, Nolte H, Laufs R.

J Clin Virol. 1999 Jun;13(1-2):43-51.

PMID:
10405891
45.

Die vertikale Übertragung des Hepatitis-C-Virus von infizierten Müttern auf ihre Kinder Das Risiko der HCV-Übertragung durch Muttermilch ist gering : Das Risiko der HCV-Übertragung durch Muttermilch ist gering.

Polywka S, Laufs R.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 1999 Jul;42(7):562-568. doi: 10.1007/s001030050156. German.

PMID:
28246707
46.

Age-dependent acquisition of hepatitis G virus/GB virus C in a nonrisk population: detection of the virus by antibodies.

Feucht HH, Schröter M, Zöllner B, Polywka S, Laufs R.

J Clin Microbiol. 1999 May;37(5):1294-7.

47.

Definition of false-positive reactions in screening for hepatitis C virus antibodies.

Schröter M, Feucht HH, Schäfer P, Zöllner B, Polywka S, Laufs R.

J Clin Microbiol. 1999 Jan;37(1):233-4.

48.

Application of nested PCR and mass spectrometry for DNA-based virus detection: HBV-DNA detected in the majority of isolated anti-HBc positive sera.

Jurinke C, Zöllner B, Feucht HH, van den Boom D, Jacob A, Polywka S, Laufs R, Köster H.

Genet Anal. 1998 Jan;14(3):97-102.

PMID:
9526701
49.

Vertebral osteomyelitis due to Rhodococcus equi in a liver transplant recipient.

Fischer L, Sterneck M, Albrecht H, Krupski G, Polywka S, Rogiers X, Broelsch CE.

Clin Infect Dis. 1998 Mar;26(3):749-52. Review.

PMID:
9524854
50.

Distribution of hepatitis G viremia and antibody response to recombinant proteins with special regard to risk factors in 709 patients.

Feucht HH, Zöllner B, Polywka S, Knödler B, Schröter M, Nolte H, Laufs R.

Hepatology. 1997 Aug;26(2):491-4.

PMID:
9252164

Supplemental Content

Loading ...
Support Center